Usted buscó: pasireiskusios (Lituano - Inglés)

toliau isvardytos pasireiskusios nepageidaujamos reakcijos.
the following adverse reactions have been reported:

dazniausiai pasireiskusios reakcijos isvardytos 4. 8 skyriuje.
the most commonly reported reactions are listed in section 4.8.

nepageidaujamos vaisto reakcijos, pasireiskusios maziau kaip 1%
adverse drug reactions occurring at a frequency of lower than 1%

kadangi pranesta apie enbrel vartojusiems pacientams pasireiskusios tuberkuliozs
as cases of tuberculosis have been reported in patients treated with enbrel, your

visos nepageidaujamos reakcijos, pasireiskusios daugini klinikini tyrim metu
all adverse reactions reported in patients in multiple clinical trials

dazniausiai pasireiskusios nepageidaujamos reakcijos buvo galvos svaigimas ir mieguistumas.
38 reactions were dizziness and somnolence.

6 2 lentel.nepageidaujamos reakcijos, pasireiskusios po desloratadino patekimo rink
adverse reactions reported during the post-marketing period for desloratadine

ne kraujui pasireiskusios nepageidaujamos reakcijos paprastai bna lengvos arba vidutinio sunkumo.
non-haematological adverse reactions are generally mild to moderate in severity.

nepageidaujamos vaisto reakcijos, pasireiskusios maziau kaip 1% arba 1% dazniu
adverse drug reactions occurring at a frequency of less than or equal to 1%

nepageidaujamos reakcijos, pasireiskusios pacientams, sirgusiems patologine miopija ir amd, buvo panasios.
undesirable effects reported in patients with pathological myopia were similar to those reported in patients with amd.

dazniausios nepageidaujamos reakcijos, pasireiskusios 10% pacient, buvo galvos skausmas ir paraudimas.
the most commonly reported adverse drug reactions occurring in 10% of patients are headache and flushing.

-jeigu jums anksciau buvo pasireiskusios odos reakcijos, t. y., odos skausmas, paraudimas ir
-if you have previously had skin reactions, i. e., pain, redness and dryness of skin, during

11 pranesim apie pasireiskusias sinkopes abej grupi pacientams.
during the 8-week treatment period, there were no reported cases of syncope in either treatment group.